| Mechanistic Modeling of SARS‐CoV‐2 and Other Infectious Diseases and the Effects of Therapeutics | journal | March 2021 | 
    | The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients | journal | March 2020 | 
    | Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis | journal | May 2020 | 
    | Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load | journal | August 2020 | 
    | Target Cell Limited and Immune Control Models of HIV Infection: A Comparison | journal | February 1998 | 
    | Modeling Plasma Virus Concentration during Primary HIV Infection | journal | April 2000 | 
    | Practical Use of the Information-Theoretic Approach | book | January 1998 | 
    | Mechanism of interferon action. Kinetics of decay of the antiviral state and protein phosphorylation in mouse fibroblasts treated with natural and cloned interferons. | journal | October 1982 | 
    | Mechanism of interferon action. I. Characterization of a 54-kDa protein induced by gamma interferon with properties similar to a cytoskeletal component. | journal | December 1987 | 
    | SARS-CoV-2 rebound with and without antivirals | journal | June 2023 | 
    | Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study | journal | November 2022 | 
    | SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract | journal | July 2020 | 
    | Adaptive immunity to SARS-CoV-2 and COVID-19 | journal | February 2021 | 
    | Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques | journal | June 2022 | 
    | Simplified within-host and Dose–response Models of SARS-CoV-2 | journal | May 2023 | 
    | Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany | journal | September 2021 | 
    | Modeling the viral dynamics of SARS-CoV-2 infection | journal | October 2020 | 
    | Collective Infectious Units in Viruses | journal | May 2017 | 
    | Rapid induction and persistence of paracrine-induced cellular antiviral states arrest viral infection spread in A549 cells | journal | September 2016 | 
    | Multi-virion infectious units arise from free viral particles in an enveloped virus | journal | May 2017 | 
    | Modelling viral and immune system dynamics | journal | January 2002 | 
    | Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness | journal | April 2022 | 
    | Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial | journal | October 2022 | 
    | Virological assessment of hospitalized patients with COVID-2019 | journal | April 2020 | 
    | Human SARS-CoV-2 challenge uncovers local and systemic response dynamics | journal | June 2024 | 
    | The T cell immune response against SARS-CoV-2 | journal | February 2022 | 
    | Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults | journal | March 2022 | 
    | Identifiability of parameters in mathematical models of SARS-CoV-2 infections in humans | journal | August 2022 | 
    | Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study | journal | October 2022 | 
    | Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19 | journal | September 2022 | 
    | Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort | journal | February 2021 | 
    | In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness | journal | December 2021 | 
    | Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics | journal | June 2021 | 
    | Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial | journal | March 2022 | 
    | SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology | journal | September 2020 | 
    | Mathematical modeling of within-host Zika virus dynamics | journal | August 2018 | 
    | Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response | journal | October 2020 | 
    | Type 1 Interferons and the Virus-Host Relationship: A Lesson in Detente | journal | May 2006 | 
    | Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon- Therapy | journal | October 1998 | 
    | How does SARS-CoV-2 cause COVID-19? | journal | July 2020 | 
    | Diversity begets stability: Sublinear growth and competitive coexistence across ecosystems | journal | March 2024 | 
    | Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2 | journal | October 2021 | 
    | Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults | journal | September 2024 | 
    | Antiviral Actions of Interferons | journal | October 2001 | 
    | Kinetics of Influenza A Virus Infection in Humans | journal | July 2006 | 
    | Dynamics of Influenza Virus Infection and Pathology | journal | February 2010 | 
    | On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics | journal | January 2011 | 
    | Modelling upper respiratory viral load dynamics of SARS-CoV-2 | journal | January 2022 | 
    | Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies | journal | July 2021 | 
    | Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions | journal | February 2011 | 
    | Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action | journal | March 2021 | 
    | SARS-CoV-2 viral dynamics in non-human primates | journal | March 2021 | 
    | Modeling within-host and aerosol dynamics of SARS-CoV-2: The relationship with infectiousness | journal | August 2022 | 
    | Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates | journal | August 2023 | 
    | How robust are estimates of key parameters in standard viral dynamic models? | journal | April 2024 | 
    | Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study | journal | July 2021 | 
    | Interplay between SARS-CoV-2 and the type I interferon response | journal | July 2020 | 
    | Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms | journal | June 2022 | 
    | Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody | journal | April 2024 | 
    | Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis | journal | September 2022 | 
    | Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets | journal | August 2021 | 
    | Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2 | journal | August 2021 | 
    | Natural Antibodies Bridge Innate and Adaptive Immunity | journal | December 2014 | 
    | Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection | journal | March 2023 | 
    | SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy | journal | December 2023 | 
    | Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset | journal | September 2020 | 
    | Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events | journal | February 2021 | 
    | Quantifying the relationship between SARS-CoV-2 viral load and infectiousness | journal | September 2021 | 
    | Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection | journal | July 2022 | 
    | Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study | journal | November 2022 |